Tizanidine Hydrochloride Capsule
NDC Package 70771-1069-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tizanidine Hydrochloride capsules is classified as a

administered via oral route. This formulation utilizes a capsule delivery system. Marketed by Zydus Lifesciences Limited, this product is identified by NDC 70771-1069 and is authorized under FDA application ANDA208622.

Identification & Billing

NDC Package Code
70771-1069-8
Package Description
150 CAPSULE in 1 BOTTLE
Product Code
70771-1069
11-Digit Billing Format
70771106908
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tizanidine Hydrochloride
Non-Proprietary Name
Tizanidine Hydrochloride
Substance Name
Tizanidine Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TIZANIDINE HYDROCHLORIDE 6 mg/1
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Zydus Lifesciences Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA208622
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-27-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70771-1069). Click a package code to view its specific billing and regulatory data.

70771-1069-4
10 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
70771-1069-5
500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70771-1069-8 identifies a specific commercial package of 150 capsule in 1 bottle of Tizanidine Hydrochloride, a human prescription drug labeled by Zydus Lifesciences Limited. This capsule is formulated for oral use and contains tizanidine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Lifesciences Limited on April 27, 2017. The current certification is valid through December 31, 2027.

How is this Zydus Lifesciences Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70771106908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70771-1069-8
11-Digit CMS (5-4-2)
70771-1069-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.